PeptideDB

Foslinanib Sodium

CAS No.: 1256037-62-3

Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM
Synonyms TRX818 Sodium
molecular weight 409.21
Molecular formula C16H11FNNa2O6P
CAS 1256037-62-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 7.86 mg/mL (19.2 mM), Sonication is recommended.
References 1. Chu, Y.-W., and Chien, D.-S. Use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry. (2016).